Eli Lilly

Healthcare

Eli Lilly Wants to Bring Pharmaceutical Production Back to the US

Photo by Jetcityimage via iStock

Eli Lilly last week announced a $27 billion investment in four different domestic manufacturing plants to boost weight-loss drug production.

1 min read

Photo by Chemist4U via CC BY-SA 2.0

Healthcare

Hims & Hers Struggles After the FDA Puts a Ticking Clock on its Weight-Loss Drug

Now that semaglutide’s no longer in shortage territory, the FDA said drug-makers have 90 days to wrap up production of their Novo knockoffs.

2 min read
Photo by Chemist4U via CC BY-SA 2.0

Healthcare

Weight-Loss Giants Have Investors Back on Their Side

It can be hard to sate investors’ appetites, but if there’s two companies who should know how to do it, it’s these two.

1 min read
Photo by News Øresund – Kristoffer Dahl via CC BY 3.0

Healthcare

Novo Nordisk May Have Another Blockbuster on its Hands

On Friday, the Danish pharma giant released the stellar results from a phase 1/2 trial for a once-weekly jab in its pipeline.

1 min read

Healthcare

2025 is the Year of the Weight Loss Pill

Photo by Chemist4U via CC BY-SA 2.0

Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.

2 min read

Healthcare

Making Weight-Loss Drugs Takes a Whole Lot of Muscle

Photo by Chemist4U via CC BY-SA 2.0

In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.

1 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.